人工智能在药物警戒中的应用:术语、概念、应用与局限性介绍
本文介绍人工智能(AI)在药物警戒中的术语、概念、应用与局限。AI工具在药物警戒中潜力巨大,但采纳缓慢;机器学习结合自然语言处理与数据挖掘,可用于电子健康记录、索赔数据库和社交媒体等数据库中的药物不良反应研究,增强已知不良反应特征刻画并检测新信号。
要点
- AI工具可增强药物警戒活动,但药物警戒专家无需成为AI专家,只需足够了解以探索合作。
- AI局限性包括语言理解困难(需理解语境和歧义)和数据库不足(需仔细准备与 curation)。
- 机器学习结合自然语言处理与数据挖掘,有潜力增强已知不良反应刻画并检测新信号。
核心结论
- AI工具在药物警戒中具有巨大潜力,但采纳缓慢。
- 机器学习结合自然语言处理与数据挖掘,有潜力增强已知不良反应特征刻画并检测新信号。
主要发现
- AI范围包括计算技能、视觉感知、专家系统决策、语言处理等方面及其组合。
- 机器可通过模拟人脑认知行动的神经网络编程学习能力,实现深度结构学习。
- AI局限性包括语言理解困难(影响翻译)和数据库不足(需仔细准备与curation)。
- 新技术可能因意外故障导致不可预见的困难。
临床怎么用
- 药物警戒专家应足够了解AI以探索与AI专家的合作。
- 可利用机器学习结合自然语言处理与数据挖掘,研究电子健康记录、索赔数据库和社交媒体等数据库中的药物不良反应。
局限性
- AI语言理解困难,需理解语境和解释歧义,尤其影响翻译。
- 数据库不足,需要仔细准备和curation。
- 新技术可能因意外故障导致不可预见的困难。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The tools of artificial intelligence (AI) have enormous potential to enhance activities in pharmacovigilance. Pharmacovigilance experts need not be AI experts, but they should know enough about AI to explore the possibilities of collaboration with those who are. Modern concepts of AI date from Alan Turing's work, especially his paper on "the imitation game", in the late 1940s and early 1950s. Its scope today includes computational skills, including the formulation of mathematical proofs; visual perception, including facial recognition and virtual reality; decision making by expert systems; aspects of language, such as language processing, speech recognition, creative composition, and translation; and combinations of these, e.g. in self-driving vehicles. Machines can be programmed with the ability to learn, using neural networks that mimic cognitive actions of the human brain, leading to deep structural learning. Limitations of AI include difficulties with language, arising from the need to understand context and interpret ambiguities, which particularly affect translation, and inadequacies of databases, requiring careful preparation and curation. New techniques may cause unforeseen difficulties via unexpected malfunctioning. Relevant terms and concepts include different types of machine learning, neural networks, natural language programming, ontologies, and expert systems. Adoption of the tools of AI in pharmacovigilance has been slow. Machine learning, in conjunction with natural language processing and data mining, to study adverse drug reactions in databases such as those found in electronic health records, claims databases, and social media, has the potential to enhance the characterization of known adverse effects and reactions and detect new signals.
引用
- Aronson JK. Artificial Intelligence in Pharmacovigilance: An Introduction to Terms, Concepts, Applications, and Limitations. Drug Saf. 2022. PMID: 35579806. doi:10.1007/s40264-022-01156-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。